[A controlled clinical study on the efficacy and tolerability of stepronin in chronic alcoholic liver diseases].
A group of 15 hospitalized chronic alcoholics was treated for 30 days with twice daily doses of 840 mg stepronin and was compared to 15 patients receiving placebo. The favorable results of this treatment are reported together with statistically significant changes of laboratory tests.
De Rensis
L
L
II Divisione di Medicina Generale, USL 42, Presidio Ospedaliero Elena d'Aosta, Napoli.
Schianchi
L
L
Assunto
A
A
Antenora
G
G
Allocca
F
F
Bossone
V
V
D000328:Adult; D000368:Aged; D004361:Drug Tolerance; D005260:Female; D005998:Glycine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008108:Liver Diseases, Alcoholic / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013440:Sulfides; D013876:Thiophenes; D013997:Time Factors
D013440:Sulfides; D013876:Thiophenes; C035227:stepronin; D005998:Glycine
Studio clinico controllato sull'efficacia e la tollerabilità dello stepronin nella epatopatia da alcolismo cronico.